Slingshot members are tracking this event:
Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia Phase 3 Study Completed
Slingshot Insights Explained
May 07, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Inhaled Amikacin Solution, Bay41-6551, Gram-negative Pneumonia